The Center for Clinical and Cosmetic Research Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2013
NCT01910831
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

The Center for Clinical and Cosmetic Research

Active Ingredients

Drugs in Phase 4 Trials (2)

apremilast (otezla) (1 trial)

vitamin a (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 4)

Purpura (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2